Cellcycle-dependentnucleocytoplasmicshuttlingoftheneuroﬁbromatosis2tumoursuppressormerlinTaruMuranen*,1,3,MikaelaGro¨nholm1,3,GHermaRenkema2andOlliCarpe´n11ProgramofNeuroscience,BiomedicumHelsinki,DepartmentofPathology,UniversityofHelsinkiandHelsinkiUniversityHospital,PB63,Helsinki00014,Finland;2InstituteofMedicalTechnology,UniversityofTampereandTampereUniversityHospital,FinlandTheneuroﬁbromatosis2tumoursuppressormerlin/schwannominisstructurallyrelatedtotheezrin–radix-in–moesinfamilyofproteins,whichanchoractincytoske-letontospeciﬁcmembraneproteinsandparticipateincellsignalling.Merlininhibitscellgrowthwithayetunknownmechanism.Asmosttumoursuppressorsarelinkedtocellcyclecontrol,weinvestigatedmerlin’sbehaviourduringcellcycle.Ingliomaandosteosarcomacells,endogenousmerlinwastargetedtothenucleusinacellcycle-speciﬁcmanner.MerlinaccumulatedperinuclearlyattheG2/Mphase,andshiftedtothenucleusatearlyG1.Duringmitosis,merlinlocalizedtomitoticspindlesandatthecontractilering.Nuclearmerlinwasstronglyreducedinconﬂuentcells.BlockingoftheCRM1/exportinnuclearexportpathwayledtoaccumulationofmerlininthenucleus.Activationofthep21-activatedkinaseorproteinkinaseA,whichresultinphosphorylationofmerlin,didnotaffectitsnuclearlocalization.Merlinregulatestheactivityofextracellularsignal-regulatedkinase2(ERK2)andnuclearlocalizationofbothproteinswasinducedbycelladhesion.UnlikeERK2,nuclearlocalizationofmerlinwasnot,however,dependentonintactactincytoskeleton.Theseresultslinkmerlintoeventsrelatedtocellcyclecontrolandmayhelptoresolveitstumoursuppressorfunction.Oncogene(2005)24,1150–1158.doi:10.1038/sj.onc.1208283Publishedonline6December2004Keywords:merlin;NF2;ERM;nucleus;cellcycleIntroductionTheneuroﬁbromatosis2(NF2)geneiscriticallyinvolvedintheformationoftumoursofthenervoussystem,especiallyschwannomasandmeningiomas.IntheNF2disease,inheritedNF2genemutationsresultinmultipletumours,andinallsporadicschwannomasandmostmeningiomassomaticbiallelicinactivationinitiatestumourdevelopment(Baseretal.,2003).ThemechanismbywhichtheNF2geneproductmerlin(schwannomin)functionsasatumoursuppressorisnotknown,althoughinvolvementineventsrelatedtocellcycleregulationhasbeensuggested.Forinstance,overexpressionofmerlininNIH3T3cellsreducesproliferation(LutchmanandRouleau,1995)andtransfectionofmerlinintohumanprimaryschwannomacellsinhibitsproliferationandpromotesG0/G1arrest(Schulzeetal.,2002).Conversely,suppressionofmerlinintumourcellsinducesproliferation(HuynhandPulst,1996)andtargeteddisruptionoftheNF2generesultsinincreasedcellproliferationandtumourformation(McClatcheyetal.,1998;Giovanninietal.,2000).Ingeneral,functionsoftumoursuppressorproteinsincluderegulationofcellularresponsestogrowth-promotingsignals,DNAdamageandcellcyclecheckpoints.Theseactivitiestypicallyrequirenuclearlocalizationofthetumoursuppressorprotein,whichmayoccurinacellcycle-speciﬁcmanner.Regulatednucleocytoplasmicshuttlingandassociationwiththenuclearenvelopeandmicrotubuleshasrecentlybeendemonstratedforseveraltumoursuppres-sorproteins,suchasadenomatouspolyposiscoli(APC),VHLandBRCA1(FabbroandHenderson,2003).Merlinisstructurallyrelatedtotheezrin,radixinandmoesin(ERM-proteins),whichactasmole-cularlinkersbetweenthecytoskeletonandspeciﬁcmembraneproteins(McClatchey,2003).ERM-proteinsaremainlyfoundinactin-richsurfaceprotrusionsoftheplasmamembranesuchasmembranerufﬂes,microspikesandinthecleavagefurrow(Bretscheretal.,2002;Gautreauetal.,2002).MerlinpartlycolocalizeswithERM-proteinsintheseregionsofdynamiccytoskeletalremodelling(Gonzalez-Agostietal.,1996;Sainioetal.,1997;Shawetal.,1998;Gusellaetal.,1999)andformsheterodimerswithERM-proteins(Gro¨nholmetal.,1999),especiallywhenphosphorylatedatS518(Alfthanetal.,2004).Owingtothissubcellulardistribution,merlinhasbeenregardedasauniquetypeoftumoursuppressor,whosegrowthinhibitorymechanismwouldbelinkedtocellsurfaceorganizationandadhesion.Weshowhere,however,thatthesubcellularlocalizationofmerlinismoreversatilethanpreviouslythought.Itsnuclearlocaliza-tionisdependentonthecellcycle,celldensityandadhesion.Received3June2004;revised11October2004;accepted12October2004;publishedonline6December2004*Correspondence:TMuranen;E-mail:taru.muranen@helsinki.ﬁ3TheseauthorscontributedequallytothisworkOncogene(2005)24,1150–1158&2005NaturePublishingGroupAllrightsreserved0950-9232/05$30.00www.nature.com/oncResultsDetectionofnuclearmerlinanditsassociationwithCRM1/exportinpathwayTostudythelocalizationofmerlin,weusedhumanU251gliomaandU2OSosteosarcomatumourcelllines,expressingendogenousmerlin.Undersubconﬂuentconditions,andstainedwiththreedifferentmerlinantibodies(Figure1),merlinwasconcentratedunder-neaththecellmembraneinlinewithearlierstudies.However,asmallfractionofcellsdemonstratedbrightnuclearstaining.Theintensityofnuclearstainingvariedamongcells,fromcellsexhibitingalmostentirelynuclearlabellingtocellswithbothnuclearandsubmembranousstaining.Insubconﬂuentcultures,theamountofcellsdemonstratingnuclearmerlinvaried(dependingontheantibody)from9to17%forU251cells,andfrom13to16%onU2OScells.Toverifythespeciﬁcityofmerlinantisera,293HEKcellsweretransfectedwithmyc-taggedmerlincDNA.Cellswerethendouble-stainedwithmycmAbandmerlinantisera(Figure1c),ortransfectedproteinwasimmunoprecipitatedwithmycmAbandtheprecipitatedmaterialwasblottedwithmerlinantibodies(Figure2c).Bothimmunostainingandco-immunoprecipitationresultsconﬁrmedthattheanti-bodiesspeciﬁcallyrecognisemerlin.Weisolatedthenuclearandcytoplasmicfractionsandimmunoblottedthemformerlin,andfornuclear,membraneandcytoplasmicmarkers(Figure2).Frac-tionationrevealedthepresenceofmerlininthenuclearaswellasinthemembranefractionandthusconﬁrmedtheimmunolocalizationresults.Figure1Endogenousmerlinispresentinthenuclei.(aandb)Immunostainingofsubconﬂuent,nonsynchronizedU251glioma(a)andU2OSosteosarcomacells(b)withthreedifferentmerlinantibodies(1398,A19andKF10)demonstratesnuclearstaininginsomecells.Subconﬂuentcultureswerequantitativelyanalysedfornuclearmerlin;12%ofU251cellsexhibitnuclearmerlin(A19:9.6%;1398:9.9%;KF10:17%)and14%ofU2OSexhibitnuclearmerlin(A19:13.4%;1398:13.5%;KF10:15.7%).Theimageswerechosentoincludecellswithnuclearandthemorefrequentmembrane/cytoplasmicstainingpattern.Totestthespeciﬁcityofthepolyclonalmerlinantibodies,293HEKcellsweretransfectedwithmyc-taggedmerlincDNA(c).CellswerestainedwithmycmAb(green)andwithpolyclonalmerlinantibodies,A19and1398(red).Mycandmerlinantibodiesreactwithtransfectedcellsonlyanddemonstrateanidenticalstainingpattern.Scalebar10mmFigure2SubcellularfractionationofU251andU2OScells.(aandb)U251(a)andU2OS(b)cellswerefractionatedandnuclear(n)andmembrane/cytoplasmic(m)fractionswereanalysedbyWesternblotting.Thethreeantibodiesidentifymerlinbothinthenuclearandinthemembrane/cytoplasmicfractions.ThenuclearmarkerMAT1isdetectedpredominantlyinthenuclearfraction,andthetransmembraneproteinCD44andthemitochondrialproteinporinexclusivelyinthemembrane/cytoplasmicfraction.The293HEKcellsweretransfectedwithmyc-taggedmerlincDNA(c).TransfectedproteinwasimmunoprecipitatedwithmycmAborcontrolX63mAbandtheprecipitatedmaterialwasblottedwithpolyclonal(A19,1398)merlinantibodiesorwithmycmAb.Allantibodiesdetectabandwiththemolecularsizeofmerlin(arrow)inmycbutnotX63mAbimmunoprecipitates.Thebandisalsodetectedintotallysatesoftransfectedcells.Thebandabove51kDacorrespondstoantibodyheavychainNucleocytoplasmicshuttlingofmerlinTMuranenetal1151OncogeneWenextanalysedwhethercelldensityaffectsthedistributionofmerlin.Immunolocalizationanalysisofmerlindemonstratedthepresenceofnuclearmerlininafractionofcellsgrowninsubconﬂuentconditions.Instead,inconﬂuentcells,merlinwaslocalizedonlytothecorticalmembraneandthecytoplasm,withoutadetectablenuclearsignal(Figure3).Laserscanningcytometricquantiﬁcationofcellsdouble-stainedformerlinandDNAveriﬁedthisﬁnding(Figure3).Nucleocytoplasmicshuttlingofproteinsisanactiveprocess,regulatedbyvariousimportandexportpath-ways(Weis,2003).Tostudythetransportofmerlin,weblockedtheCRM1/exportin-mediatednuclearexportwithleptomycinB(LMB)(Kudoetal.,1998).LMBtreatmentofU251cellsresultedinamarkedincreaseinnuclearmerlinasdemonstratedbothbyimmunoﬂuor-escencemicroscopyandlaserscanningcytometry(LSC)(Figure3).After2hLMBtreatment,mostofthesubconﬂuentcellsdemonstratednuclearmerlinandsomenuclearaccumulationwasalsoseeninconﬂuentcells.NuclearlocalizationwasalsoevidentinU2OScellsandtheresultsforbothcelllineswereconﬁrmedwithallmerlinantibodies(notshown).NuclearshuttlingofmerlinislinkedtocellcycleThedifferentialnuclearlocalizationofmerlininsubconﬂuentcellssuggestedthatnucleartargetingmightoccurinacellcycle-speciﬁcmanner.Inordertostudythelocalizationofmerlinindifferentphasesofthecellcycle,subconﬂuentU251cellsweresynchronizedusingnocodazoleormimosinetreatment.Nocodazoledepo-lymerizesmicrotubulesreversiblyandblockscellsattheG2/Mphase,whereasmimosineaffectsthereplicationforkandblockscellsatearlySphase.FACSanalysiswasusedtoconﬁrmtheefﬁciencyofsynchronizationandtomonitorthecellcyclephaseafterblockrelease.Incellsabouttoentermitosis(lateG2/M),merlinwaslocalizedinthecytoplasmandconcentratedtotheperinuclearregion(Figure4).Duringearlymitosis,merlinwascondensedaroundthebreakingnuclearenvelope,especiallyinnuclearenvelopeinvaginations,thatis,regionsinwhichmicrotubulesareconcentratedFigure3CellconﬂuencyandLMBtreatmentaffectnuclearlocalizationofmerlin(aandd).Subconﬂuent(a)orconﬂuent(b)U251cellsweredouble-stainedwithmerlinantibody(A19)andwithaDNA-bindingnuclearprobe(TO-PRO).Incontrasttosubconﬂuentcells,inwhichnuclearmerlinisdetected,merlininconﬂuentcellsislocalizedunderneaththecorticalmembranesandinthecytoplasmandisabsentfromthenucleus.CRM1/exportininhibitorLMBtreatmentofsubconﬂuentcellsresultsinnuclearaccumulationofmerlin(c).IncreasednuclearstainingisalsodetectedinconﬂuentcellsafterLMBtreatment(d).Scalebar10mm.(e)LSCdemonstratesquantitativedifferencesinnuclearmerlincontentinsubconﬂuent,conﬂuentandLMB-treatedcells.Propidiumiodidestaining(redﬂuorescence)wasusedtodeﬁnethenuclearareaandmerlinstaining(green)inthenucleiwasquantiﬁedeitherasmaximumpixelintensity(left)ortotalﬂuorescenceinthenuclei(right).Thepercentageofcellswithmerlin-positivenucleiisshownintoprightcornerofeachplot.ThisisarepresentativeofthreeexperimentsNucleocytoplasmicshuttlingofmerlinTMuranenetal1152Oncogeneintheprophase(BurkeandEllenberg,2002).Aftermitosis,atearlyG1,merlinaccumulatedtothenucleus,andatthispointastrongsignalwasalsodetectedunderneaththecorticalmembrane.ProgressionofthecellcycletolateG1phaseresultedinexportofmerlinfromthenucleus.AtG1/S,merlinconcentratedunder-neaththecorticalmembraneand,lessprominently,totheperinuclearregion.Furtheranalysisofmerlinindividingcellsdemonstratedapatternresemblingmitoticspindlesinmetaphasecellsandconcentrationtothemid-bodyduringcytokinesis(Figure4).SubcellularfractionationofsynchronizedU251cellswasperformedtofurtheranalysethedistributionofmerlinatdifferentcellcyclephases.FACSanalysiswasusedtoconﬁrmthesynchronization(resultsnotshown)andmembraneandnuclearmarkerswereusedtoverifythepurityofsubcellularfractions.Cellstreatedwithmimosineandfractionatedatblockrelease(lateG1/S)or5hlater(Sphase)showedonlyverylittlemerlininthenucleus,whereasthesametreatmentwithnocoda-zoleresultedinstrongmerlinreactivityinthenuclearfractionatthetimeofrelease(G2/M)andaweakerreactivity5hlater(mid-G1)(Figure5).PhosphorylatedmerlinispresentbothinthenuclearandcytoplasmicfractionsMerlinhasbeenshowntophosphorylateatserine518byp21-activatedkinase(PAK)andproteinkinaseA(PKA)(Kissiletal.,2002;Xiaoetal.,2002;Alfthanetal.,2004).Thephosphorylatedandnonphosphory-latedformsofmerlincanbeidentiﬁedbydifferentialmobilityinSDS–polyacrylamidegels(PAGE).AsshowninFigure5,boththehypophosphorylatedandthephosphorylatedformsofmerlinweredetectedatalltimepointsbothinthenuclearandthecytoplasmicFigure5Merlininsubcellularfractionsofsynchronizedcells.U251cellsweretreatedeitherwithnocodazole(Noc),whichblocksthecellcycleatG2/Morwithmimosine(Mimo),whichblocksthecellcycleatthebeginningoftheSphase,afterwhichtheblockwasreleased.Cellswerefractionatedimmediatelyor5hafterreleaseoftheblockandnuclear(n)ormembrane/cytoplasmic(m)fractionswereanalysed.PurityofthefractionswasveriﬁedwithacytoplasmicmarkerCD44andanuclearmarkerMAT1.MerlinwasdetectedwithKF10mAbandtheS518phosphorylatedmerlinwasdetectedwithS518-phospho-speciﬁcantibody.Also,totalextractsofthesynchronizedcellsareincluded.ThecellcyclephaseandsynchronizationwasveriﬁedbyFACSanalysis(notshown)Figure4Subcellularlocalizationofmerlinisdependentoncellcycle.(a–g)U251cellsweresynchronizedwithnocodazoleandstainedformerlin(NF21398pAb,green)andDNA(TO-PRO,red)atvariousphasesofthecellcycleandanalysedbyconfocalmicroscopy.ThecellcyclephasewasveriﬁedbyFACSanalysis.Threedifferentsections(dorsal,middleandventral)areshown.ThecellsattheG2/Mphase(a)(FACSanalysis:G2/M98.3%,G0/G11.5%,S0.2%)showperinuclearaccumulationofmerlin.Atearlymitosis(b),merlinisconcentratedaroundthebreakingnuclearenvelope,andthestainingpatternisretainedattheonsetofmitosis(c).InearlyG1(d),intensenuclearmerlinstainingisdetected(FACSanalysis:G2/M71.9%,G0/G115.6%,S12.5%).LaterintheG1/Sphase(FACSanalysis:G2/M14.0%,G0/G139.1%S46.9%),merlinisabsentfromthenucleusandisconcentratedunderneaththecellmembraneandinthecytoplasm(e).Inmitoticcells,merlinstainingcoincideswithmitoticspindles(f)andduringcytokinesismerlinisseenarounddevelopingnuclearenvelopeandatmid-body(g).Scalebar10mmNucleocytoplasmicshuttlingofmerlinTMuranenetal1153Oncogenefraction.FurtherconﬁrmationforthepresenceofphosphorylatedmerlininbothfractionswasobtainedbyimmunoblottingwithanS518phospho-speciﬁcmerlinantibody(Figure5).Wefurtherstudiedwhetheralterationofthekinaseactivitychangesthedistributionofmerlinatacellularlevel.WetransfectedU251cellswithadominant-negativePAK2construct(inhibitoryCRIBdomain),knowntoinhibitendogenousPAKactivity(Alfthanetal.,2004)and/orincubatedthecellswithH89,whichblocksthePKAsignallingpathway.Thistreatmenthasbeenshowntoeffectivelyblockphosphorylationofmerlin(Alfthanetal.,2004).Inthesecells,nuclearmerlinstainingwasstillevident(Figure6).WealsostudiedtheeffectofactivationofPAKandPKAactivityonthenuclearlocalizationofmerlin.U251cellsweretransfectedwithconstitutivelyactivePAK2con-structandincubatedfor30minwithIBMXandforskolin,whichstimulateendogenousPKAactivityincells.Thistreatmentdidnotinduceanychangesinthenuclearlocalizationofmerlin(Figure6).Theexperi-mentwasalsoperformedwithstimulatedPKAtogetherwithinhibitedPAKandviceversa.Noneofthetreatmentschangedthenuclearlocalizationofmerlin.MerlinistargetedtothenucleusatearlyphaseofcellattachmentDuringmitosis,cellsroundupandareonlylooselyattachedtothesubstratum.Aftercelldivision,theyattachtosubstratummoreﬁrmlyandspreadagain.Westudiedwhetherlocalizationofmerlinwouldbeaffectedbycellattachmentandspreading,whichtakeplaceshortlyaftermitosisatG1.Thiswastestedbyeithertrypsinizingnonsynchronized,subconﬂuentU251cellsor,alternatively,byshakingoffmitoticcells(notshown)andlettingthemreattachforashorttime.CellsatvarioustimepointsofreattachmentwereﬁxedandstainedformerlinandF-actin.Astrongnuclearmerlinstainingwasdetectedatearlyphasesofreattachment,bothaftermitoticshakeoffandtrypsinization(Figure7).Atlatertimepoints(>1h),whenthecellswerespreadandthecorticallamellipodialactinnet-work,typicalofmigratingcells,wasformed,merlinwasagainconcentratedunderneaththemembraneandnuclearlocalizationdisappeared(Figure7).Actincytoskeletonisnotrequiredforadhesion-dependentnucleartargetingofmerlinAdhesionandcellspreadinginducenucleartargetingofphosphorylatedextracellularsignal-regulatedkinase(ERK)viaamechanismthatrequiresintactactincytoskeleton.NucleartargetingofphosphorylatedERKisrequiredforcellcycleprogressionatG1(Aplinetal.,2001;Lohezetal.,2003).MerlinprolongstheG1phaseofthecellcycle(Schulzeetal.,2002),possiblyviainhibitionofphosphorylationofERKandERK-Figure6RegulationofPAKandPKAactivitydoesnothaveadirecteffectonmerlinnuclearlocalization.U251cellsweretransfectedeitherwithdominant-negativePAK2construct(dnPAK)(a)orconstitutivelyactivePAK2(activePAK)(b).dnPAK-expressingcellswereincubatedfor5hwithPKAinhibitorH89beforeﬁxation.CellsexpressingactivePAKwereincubatedfor30minwithIBMXandforskolinbeforeﬁxation.MerlinwasdetectedwithNF21398antibody(red)andtransfectedcellswithMycmAbfordnPAK(green)orHAmAbforconstitutivelyactivePAK(green).Neithertreatmenthasadirecteffectonmerlinnuclearlocalization.Scalebar10mmFigure7Merlinistargetedtothenucleiofattachingcells.U251cellsweretrypsinizedandﬁxed(a)orallowedtoreattachoncoverslips.Attachingcellswereﬁxedafter30(b)or90min(c).MerlinwasstainedwithNF21398Ab(red),nucleuswithTO-PRO(blue)andF-actinwasvisualizedwithOregongreenphalloidin.Merlinisheavilyaccumulatedinthenucleiduringearlyphasesofattachment.Scalebars,(a):5mmand(b,c)10mmNucleocytoplasmicshuttlingofmerlinTMuranenetal1154OncogenedependentElk-1(Limetal.,2003).WewantedtostudywhethermerlinandERKhavesimilarrequirementsforadhesion-dependentnuclearlocalization,andwhethertheycolocalizeincellswithorwithoutintactactincytoskeleton.Inuntreatedadheringcells,merlincolo-calizedwithERK2inthenucleus(Figure8).Whenadheringcellswereeitherserumstarvedorgrowninserum(notshown)andtreatedwithcytochalasinD(CCD),whichdoesnotaffectcellattachmentbutpreventscellspreadingbydisruptingtheactincytoske-leton,merlinstillremainedinthenucleus.Instead,ERK2wasconcentratedoutsidethenuclearmembraneinlinewithpreviousﬁndings(Lohezetal.,2003),andnocolocalizationwasseenbetweenthetwoproteins(Figure8).Thisresultdemonstratesthatmerlin’snuclearlocalizationisnotdependentonthenuclearlocalizationofERK,cellspreadingnoranintactactincytoskeleton.However,celladhesionisrequiredforthenuclearlocalizationofmerlin,sinceinnonadherentcellsmerlinisconcentratedtothesubmembranousregions(Figure7).DiscussionRegulatedmovementbetweenthenucleusandcyto-plasmprovidesanefﬁcient,simpleandrapidwayfortumoursuppressorstocontrolcellgrowth.Indeed,duringrecentyears,manyoftheknowntumoursuppressorshavebeenshowntoundergonucleocyto-plasmicshuttling(FabbroandHenderson,2003).Althoughsomestudies,especiallyusingtransfectedmutatedmerlin,haveshownthatitcanbetargetedtothenucleusandthatitsexportisregulatedbytheCRM1pathway(KresselandSchmucker,2002),merlinisgenerallyregardedasacomponentofthecorticalactincytoskeleton.Therefore,itstumoursuppressormechan-ismhasbeenconsideredunique.MerlinregulatescellgrowthbyprolongingtheG0/G1phaseofthecellcycle(Schulzeetal.,2002),butithasnotbeenevidentastohowasubmembranousproteincoulddothis.Ourcurrentresultsprovideacluebydemonstratingthatendogenousmerlinundergoescellcycle-andanchorage-dependentnucleocytoplasmicshuttlinginanalogywithmanyothertumoursuppressorproteins.Theamino-terminalpartofmerlincontainsanFERMdomainsharedbyseveralcytoskeletalmoleculesincludingband4.1proteins.Severalisoformsofband4.1proteinsaretargetedtothenucleusbynuclearlocalizationsignals(NLS)thatactinahierarchicalmanner(Correas,1991;DeCarceretal.,1995;LallenaandCorreas,1997).AnimportantNLSinband4.1proteinsisastretchofbasicresidues(KKKR),whichissuggestedtobindtoanegativelychargedmotifofimportin(Gascardetal.,1999).Merlincontainsananalogousstretchofbasicresidues(309RRRK312),whichmaybeinvolvedinitsnucleartargeting.Afurtheranalogybetweenmerlinandband4.1proteinisoformsistheirassociationwithmitoticspindlesduringearlymitosis(Kraussetal.,1997;Mattagajasinghetal.,1999).AccordingtoKresselandSchmucker(2002),merlinexon2hasacytoplasmicretentionsignal,whichkeepsmerlininthecytoplasm.Thus,theremaybeseveralsignalmotifswithoppositeeffects,whoseinter-playdictatesthecellcycle-dependentdistributionofmerlin.Unfortunately,ourexperimentswithtransientlytransfectedwild-typemerlinhavenotbeenabletoshowaclearnuclearlocalizationoftheoverexpressedasendogenousprotein.Forthisreason,wehavenottestedhowdisruptionofthepotentialNLSwouldaffectitsnuclearlocalization.Wehypothesizethatthelackofclearnucleartargetingoftransfectedproteinisduetooverexpression,butthereasonforthisdosedependencyinsubcellularlocalizationremainstobestudiedfurther.Timepointassayswithendogenousmerlinimplythattargetingtothenucleusisstrictlycontrolledbycellcyclephase.Merlinisassociatedwithmitoticspindlesduringmitosis(Muranenetal.,inpreparation)andispresentinthenucleusatearlyG1butnotatlateG1,SorG2phase.ThenuclearlocalizationisseeninactivelyproliferatingcellsbutnotincellsinﬂuencedbyFigure8Nuclearlocalizationofmerlinisnotdependentonintactactincytoskeleton.U251cellswereserumstarved,trypsinizedandreattachedonﬁbronectin-coatedcoverslipswithoutserumandincubatedwithout(a)orwithCCD(b).MerlinwasvisualizedwithNF21398Ab(red),ERK2withmAb(green)andnucleiweredetectedwithTO-PRO3nuclearprobe(blue).ConfocalmicroscopicanalysisofuntreatedcellsdemonstratescolocalizationofmerlinandERK2inthenuclei.Inadheringcells,CCDtreatmentpreventsnucleartargetingofERK2,whereasmerlinisstilltargetedtothenuclei.Scalebar10mmNucleocytoplasmicshuttlingofmerlinTMuranenetal1155Oncogeneconﬂuencyorcontactinhibition.AsimilarpatternofexpressionhasalsobeenshownfortheAPCandVHLtumoursuppressors,whichlocalizemostlyinthecytoplasmofconﬂuentcellsandshifttothenucleusinsubconﬂuentcellsandaffectgrowthincellcycle-dependentmanner(Leeetal.,1996;Zhangetal.,2001).Thenucleocytoplasmicshuttlingmayalsopro-videmeansformerlintoaffectcellgrowthinthesamemanner.ImmunolocalizationstudiesofadheringU251cells,eitheraftertrypsinationormitoticshakeoff,indicatethatmerlinaccumulatestothenucleusatearlypointsofcellattachment.AdhesionandanchoragetothesubstratumareknowntoregulatecellcycleprogressionatearlyG1(AssoianandZhu,1997).OneofthekeymoleculesisERK,whoseactivitydependsonintegrin-mediatedcelladhesionandthepresenceofanintactactincytoskeleton.PhosphorylationofERKanditstranslocationfromthecytoplasmtothenucleusisrequiredforcellcycleprogressionatG1.AdownstreamtargetofERKinthenucleusistheElk-1transcriptionfactor.PhosphorylatedElk-1hasincreasedafﬁnitytotheserumresponseelementandenhancestranscriptionofgrowth-relatedproteins(Maraisetal.,1993;Whit-marshetal.,1995;Vanhoutteetal.,2001),ultimatelyleadingtotheinductionofacellcycleproteincyclinD1whichregulatesthepassagethroughG1.BothmerlinandERKarelocalizedinthenucleusofadheringcellsandatearlyG1phaseofthecellcycle.ThisisofinterestinlightofarecentstudythatshowedthatmerlininhibitsphosphorylationofERKaswellasERK-dependentnuclearElk-1phosphorylation(Limetal.,2003).However,inCCD-treatedcellsinwhichElk-1phos-phorylationisimpairedandERKisunabletolocalizetothenucleus(Aplinetal.,2001),merlinisstillfoundinthenucleus.ThisimpliesthatmerlinandERKaretargetedtothenucleusviadifferentpathwaysandthatnuclearlocalizationofmerlindoesnotdependonERK’sactivity.Therearetwoadditionalinterestingmolecularpartnersofmerlin,paxillinandsyntenin,whosenucleocytoplasmicshuttlinghasrecentlybeendemonstrated.Bothofthesemoleculespossesstran-scriptionalpotential(Aplin,2003),andthereforetheirinteractionwithmerlinshouldbestudiedwithanovelperspective.Furthermore,averyrecentstudydemon-stratedthathumanpolyomavirusT-antigen,whichisabletotransformcellsofneuralorigin,isincomplexwithmerlininthenucleusofmalignantperipheralnervesheattumours(Shollaretal.,2004).Interestingly,theauthorsreportthepresenceofmerlininafractionofunsynchronizedtumourcellsinlinewithourﬁndings.Theactivityofmerlinisregulatedbyphosphoryla-tion.Twotypesofkinases,PAK-1/2andPKA,havebeenshowntophosphorylatemerlin(Kissiletal.,2002;Xiaoetal.,2002;Alfthanetal.,2004).TheactivityofPAKsisstronglyregulatedbyadhesion.Therefore,regulationofthenuclearlocalizationofmerlinbyphosphorylationisatemptingpossibility.However,wefoundphosphorylatedmerlinbothinthenuclearandcytoplasmicfractionsanddidnotﬁnddirectevidencethatactivationorinhibitionofPAKand/orPKAwouldhaveanobviouseffectonitsnuclearlocalization.However,wecannotexcludethepossibilitythattherewouldbeanindirectlinkbetweenPAK-dependentphosphorylationofmerlinanditssubcellulartargeting.Inconclusion,ourstudyidentiﬁestwocellcyclephases,mitosisandearlyG1phase,withnovelspeciﬁctargetingofmerlin.Theseobservationsindicatethatmerlinmayshareactivitiesofothertumoursuppressorproteinsandmayprovideanovelbasisfortheunder-standingofthebiologicalfunctionsofmerlin.MaterialsandmethodsCellculture,transfectionsandantibodiesU2OSosteosarcomacellsweremaintainedinDulbecco’smodiﬁedEagle’smediumwith1%nonessentialaminoacids,supplementedwith15%foetalcalfserum(FCS)(PromoCell,Heidelberg,Germany),andU251gliomacellsweremaintainedinDulbecco’sminimumessentialmedium,supplementedwith10%FCS.The293HEKcellsweremaintainedinRPMImediumsupplementedwith10%FCS.Cellswereﬁxedin3.5%paraformaldehyde(pH7.5).CellsweretransfectedwithFugene6(Roche,Mannheim,Germany)reagentandincubatedfor48hbeforeanalysis.PKAwasstimulatedbyIBMX(50mM)andforskolin(25mM)for30minandinhibitedby5hincubationwithH89(20mM)(allprovidedbySigma,StLouis,USA).ConstitutivelyactivePAK(T402Emutant)andtheinhibitoryN-terminalPAK2construct(PAK21-248H82/85L)wereusedasdescribed(Alfthanetal.,2004).Anti-merlinpolyclonalAbA-19sc-331(SantaCruzBiotechnology,SantaCruz,CA,USA),1398NF2(denBakkeretal.,1995),anti-schwannomin(LutchmanandRouleau,1995)andmAbKF10(denBakkeretal.,1995)wereused.HM2175antiserum(Kissiletal.,2002),kindlyprovidedbyDrJKissil(MassachusettsInstituteofTechnology,Cambridge,MA,USA),wasusedtodetectS518phosphorylatedmerlin.Anti-MAT1ﬂ-309(SantaCruzBiotechnology)pAbandCD44mAbHermes-3(Jalkanenetal.,1987)wereusedinWesternblotting.TO-PRO3-iodideprobe(MolecularProbes,Eugene,OR,USA)wasusedforDNAstaining.MycmAb(CovanceResearchProductsInc.,Princeton,NJ,USA)wasusedtodetecttaggedN-terminaldomainofPAK2andHAmAb(Roche)todetecttaggedconstitutivelyactivePAK2.Anti-a-tubulinmAbN356(AmershamPharmaciaBiotech,Buck-inghamshire,England)wasusedtodetecttubulinandpropidiumiodidetostainthenucleiinLSCandFACSanalysis.Anti-porinmAb(MolecularProbes)wasusedasacytoplasmicmarker.RabbitERK2Ab(SantaCruzBiotech-nology)wasusedtodetectERK2andOregongreen-andrhodaminephalloidin(MolecularProbes)wereusedtodetectF-actin.X63mAb(ATCC)wasusedasanegativecontrol.Alexa-488-,Alexa-568-andAlexa-594-conjugatedgoatanti-mouseandgoatanti-rabbitantibodies(MolecularProbes)wereusedassecondaryantibodiesinimmunoﬂuorescenceandHRP-conjugatedrabbitanti-mouseandswineanti-rabbitsecondaryantibodies(DAKOA/S,Glostrup,Denmark)inWesternblotanalysis.Subcellularfractionationandco-immunoprecipitationNuclearextractkit(ActiveMotif,Rixensart,Belgium)wasusedfornuclearandcytoplasmicfractionation.ProteinconcentrationineachfractionwasmeasuredwithBradfordNucleocytoplasmicshuttlingofmerlinTMuranenetal1156OncogeneA595assayandequalamountsofproteinwereloaded.Forimmunoblotting,proteinswereseparatedon8%SDS–PAGE,transferredtonitrocellulosemembranes(Schleicher&Schuell,Dassel,Germany)andimmunoblottedproteinsweredetectedbyenhancedchemiluminescence(AmershamPharmaciaBio-tech).The293HEKcellsweretransfectedwithmyc-taggedmerlincDNAinpcDNA3vector.After48h,thecellswerelysedinELB-NP40buffer.Immunoprecipitationswereper-formedbyadding6mgofmycorX63mAbto300mgofcelllysate.Lysateswereincubatedwiththeantibodiesfor1hatþ41Cbeforetheadditionof30mlofProteinG–Sepharosebeads(AmershamPharmaciaBiotech),afterwhichincubationwascontinuedovernightat41C.Beadswereprecipitatedbycentrifugation(500r.p.m.,5min)andwashedthreetimes(ELB).Beadswereelutedin30mlof2reducingLaemmlibufferat951C.Ameasureof15mlofreactionswasrunonSDS–PAGE(8%).CellcyclesynchronizationandtreatmentsForcellcyclesynchronization,U251andU2OScellsweretreatedwithnocodazole(200–400ng/ml,Calbiochem,SanDiego,CA,USA)orL-mimosine(200–400mM,Calbiochem).After18–24h,theblockwasreleased.Atvarioustimepointsafterrelease,samplesweretakenforFACSanalysis,immuno-ﬂuorescenceandlaserscanningconfocalmicroscopy.Cellswerenotgrowntoconﬂuencyduringtheexperiments.CellsfortheCRM1-dependentnuclearexportinhibitionexperimentweretreatedwithLMB5ng/ml(Sigma)for2h.Cellsfromone10cmplatewerelysedateachtimepointinELB-NP40buffer(150mMNaCl,50mMHEPES(pH7.4),5mMEDTA,0.5%NP40,1mMEDTA,10mMNa4P2O7,50mMNaF,1mMorthovanadate,1.5mMocadaicacidandproteaseinhibitors,0.5%NP40)andcentrifugedfor30minat20000g.ProteinamountsfromeachsupernatantwereequalizedandanalysedbyWesternblotting.Ameasureof5mlofPBSwasswirledoversubconﬂuent10cmplatesandtheplateswereshakenheavilytodetachmitoticcells.Cellswerecollectedandrunontocytocentrifugeslides(700r.p.m.,5min).Fordisruptionofthecytoskeleton,cellswereserumstarvedfor24h,trypsinizedandreattachedfor2honﬁbronectin-coatedcoverslipseitherwithorwithout10%FCSandwith1mMCCD(Sigma).ImmunoﬂuorescenceandlaserscanningconfocalmicroscopyFixedcellswerepermeabilizedin0.1%TritonX-100/PBSandstainedwithmerlinandtubulinantibodiesfollowedbysecondaryantibodies.CoverslipsweremountedinDABCO(Sigma)andMowiol(Calbiochem)andexaminedbyconfocalmicroscopy(LeicaSP2equippedwithArandKrlasers,LeicaMicrosystems,Heerbrugg,Switzerland)usingthesequentialscanningmodeorbyimmunoﬂuorescencemicroscopy(ZeissAxiophotequippedwithAxioCamcooledCCDcamera,CarlZeiss,Esslingen,Germany).Foranalysisofcellswithnuclearmerlinstaining,400–600cellsperantibodywerecalculated.FlowandLSCFlowcytometricanalysiswasperformedwithaFACSCalibur(Beckton-Dickinson,SanJose,CA,USA).Cellsfromone10cmplateweretrypsinized,washedinPBStwice,resuspendedandﬁxedin70%ethanol.Cellsweredyedwithpropidiumiodidefor15minatþ371C,afterwhichtheDNAamountwasmeasuredandanalysed.ForLSC,cellswerestainedwithmerlinantibodyA19followedbyAlexa-488-conjugatedsecondaryantibodyandwithpropi-diumiodide(25mg/mlin50%glycerol)andanalysedwithalaserscanningcytometer(CompuCyteCorp.,Cambridge,MA,USA)usingargonionlaserexcitationat488nm.Fluorescencewascollectedbyphotomultipliertubeswithgreen(530DF30)andred(600DF60)bandpassﬁltersanddigitizedto0.25mm0.5mmpixelresolution.Thenucleiwereidentiﬁedbypropidiumiodidepositivityandmerlinstaininginthenucleicalculated(totalﬂuorescenceandmaximalpixelﬂuorescence).Atotalof500–2000cellspersamplewereanalysed.AbbreviationsAPC,adenomatouspolyposiscoli;CCD,cytochalasinD;ERK2,extracellularsignal-regulatedkinase2;ERM,ezrin–radixin–moesin;LMB,leptomycinB;LSC,laserscanningcytometry;NF2,neuroﬁbromatosis2.AcknowledgementsWethankDrEllenZwarthoffforgenerouslyprovidingthe1398andKF10antibodies,DrJosephKissilforprovidingtheHM2175antibody,HanneAhola,HelenaAhola,TuulaHalmesvaaraandMonicaSchoultzforskillfultechnicalassistanceandKaijaAlfthan,LeenaHeiska,MikkoRo¨ntyandAnuWartiovaaraforfruitfuldiscussionsandassistance.ThisworkwassupportedbytheUSArmyNeuroﬁbromatosisResearchGrantDAMD17-00-0550andtheAcademyofFinland.ReferencesAlfthanK,HeiskaL,Gro¨nholmM,RenkemaHandCarpe´nO.(2004).J.Biol.Chem.,279,18559–18566.AplinAE.(2003).FEBSLett.,534,11–14.AplinAE,StewartSA,AssoianRKandJulianoRL.(2001).J.CellBiol.,153,273–281.AssoianRKandZhuX.(1997).Curr.Opin.CellBiol.,9,93–98.BaserME,EvansRDGandGutmannDH.(2003).Curr.Opin.Neurol.,16,27–33.BretscherA,EdwardsKandFehonRG.(2002).Nat.Rev.Mol.Cell.Biol.,3,586–599.BurkeBandEllenbergJ.(2002).Nat.Rev.Mol.Cell.Biol.,3,487–497.CorreasI.(1991).Biochem.J.,279,581–585.DeCarcerG,LallenaMJandCorreasI.(1995).Biochem.J.,312,871–877.denBakkerMA,RiegmanPH,HekmanRA,BoersmaW,JanssenPJ,vanderKwastTHandZwarthoffEC.(1995).Oncogene,10,757–763.FabbroMandHendersonBR.(2003).Exp.CellRes.,282,59–69.GascardP,NunomuraW,LeeG,WalenskyLD,KraussSW,TakakuwaY,ChasisJA,MohandasNandConboyJG.(1999).Mol.Cell.Biol.,10,1783–1798.GautreauA,LouvardDandArpinM.(2002).Curr.Opin.CellBiol.,14,104–109.GiovanniniM,Robanus-MaandagE,vanderValkM,Niwa-KawakitaM,AbramowskiV,GoutebrozeL,WoodruffJM,BernsAandThomasG.(2000).GenesDev.,14,1617–1630.Gonzalez-AgostiC,XuL,PinneyD,BeauchampR,HobbsW,GusellaJandRameshV.(1996).Oncogene,13,1239–1247.NucleocytoplasmicshuttlingofmerlinTMuranenetal1157OncogeneGro¨nholmM,SainioM,ZhaoF,HeiskaL,VaheriAandCarpe´nO.(1999).J.CellSci.,112,895–904.GusellaJF,RameshV,MacCollinMandJacobyLB.(1999).Biochim.Biophys.Acta,1423,M29–M36.HuynhDPandPulstSM.(1996).Oncogene,13,73–84.JalkanenM,RapraegerA,SaundersSandBernﬁeldM.(1987).J.CellBiol.,105,983–990.KissilJL,JohnsonKC,EckmanMSandJacksT.(2002).J.Biol.Chem.,277,10394–10399.KraussSW,LarabellCA,LockettS,GascardP,PenmanS,MohandasNandChasisJA.(1997).J.CellBiol.,137,275–289.KresselMandSchmuckerB.(2002).Hum.Mol.Genet.,11,2269–2278.KudoN,WolffB,SekimotoT,SchreinerEP,YonedaY,YanagidaM,HorinouchiSandYoshidaM.(1998).Exp.CellRes.,242,540–547.LallenaMJandCorreasI.(1997).J.CellSci.,110,239–247.LeeS,ChenDYT,HumphreyJS,GnarraJR,LinehanWMandKlausnerRD.(1996).Proc.Natl.Acad.Sci.USA,93,1770–1775.LimJY,KimH,KimYH,KimSW,HuhPW,LeeKH,JeunSS,RhaHKandKangJK.(2003).Biochem.Biophys.Res.Commun.,302,238–245.LohezOD,ReynaudC,BorelF,AndreassenPRandMargolisRL.(2003).J.CellBiol.,161,67–77.LutchmanMandRouleauGA.(1995).CancerRes.,55,2270–2274.MaraisR,WynneJandTreismanR.(1993).Cell,73,381–393.MattagajasinghSN,HuangSC,HartensteinJS,SnyderM,MarchesiVTandBenzEJ.(1999).J.CellBiol.,145,29–43.McClatcheyAI.(2003).Nat.Rev.Cancer,3,877–883.McClatcheyAI,SaotomeI,MercerK,CrowleyD,GusellaJF,BronsonRTandJacksT.(1998).GenesDev.,12,1121–1133.SainioM,ZhaoF,HeiskaL,TurunenO,denBakkerM,ZwarthoffE,LutchmanM,RouleauGA,JaaskelainenJ,VaheriAandCarpenO.(1997).J.CellSci.,110,2249–2260.SchulzeKM,HanemannCO,MullerHWandHanenbergH.(2002).Hum.Mol.Genet.,11,69–76.ShawRJ,McClatcheyAIandJacksT.(1998).CellGrowthDiffer.,9,287–296.ShollarD,DelValleL,KhaliliK,OtteJandGordonJ.(2004).Oncogene,23,5459–5467.VanhoutteP,NissenJL,BruggB,GasperaBD,BessonMJ,HipskindRAandCabocheJ.(2001).J.Biol.Chem.,276,5189–5196.WeisK.(2003).Cell,112,441–451.WhitmarshAJ,ShoreP,SharrocksADandDavisRJ.(1995).Science,269,403–407.XiaoGH,BeeserA,ChernoffJandTestaJR.(2002).J.Biol.Chem.,277,883–886.ZhangF,WhiteRLandNeufeldKL.(2001).Mol.Cell.Biol.,21,8143–8156.NucleocytoplasmicshuttlingofmerlinTMuranenetal1158Oncogene